Synergy Life Science Partner

Investor type Venture Capital
Founders John Onopchenko Richard Stack William Starling

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 18
Average round size
info
The average size of a deal this fund participated in
$22M
Portfolio companies 7
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.61
Exits 5
Key employees 2
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Health Care
  • Medical Device
  • Biotechnology
  • mHealth
  • Health Diagnostics
Summary

The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the Portola Valley.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Manufacturing. The fund has exact preference in a number of founders of portfolio startups. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Barosense, Oraya Therapeutics, NeuroTronik

The fund is generally included in less than 2 deals every year. The important activity for fund was in 2009. The common things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2018. Comparing to the other companies, this Synergy Life Science Partner performs on 1 percentage points less the average number of lead investments. The real fund results show that this VC is 3 percentage points less often commits exit comparing to other companies.

The fund was created by John Onopchenko, Richard Stack, William Starling. The overall number of key employees were 2.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Synergy Life Science Partner, startups are often financed by U.S. Venture Partners (USVP), Mohr Davidow Ventures, Medtronic. The meaningful sponsors for the fund in investment in the same round are U.S. Venture Partners (USVP), Mohr Davidow Ventures, Medtronic. In the next rounds fund is usually obtained by Mohr Davidow Ventures, U.S. Venture Partners (USVP), Medtronic.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Synergy Life Science Partner:
Typical Co-investors
Synergy Life Science Partner is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Synergy Life Science Partner:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Accelerating Asia Central Region, Singapore, Singapore
AECAL -
Bankia Community of Madrid, Madrid, Spain
Capital Growth Geneva, Geneve, Switzerland
Clark Enterprises Bethesda, Maryland, United States
Emirates Islamic Dubai, United Arab Emirates
Global PMX -
Heidelberg Engineering Baden-Wurttemberg, Germany, Heidelberg
Huoban Chuangtou Beijing, China, Haidian
ifund foundation Rotterdam, The Netherlands, Zuid-Holland
IKEA Bootcamp Älmhult, Jonkopings Lan, Sweden
InterVideo California, Fremont, United States
Israel Industrial Resources Israel, Tel Aviv, Tel Aviv District
Kerlink Bretagne, France, Rennes
Paladin Asset Management China, Guangdong, Shenzhen
Partners Resolute New York, New York, United States
Rewe Group Cologne, Germany, Nordrhein-Westfalen
Starfish Ventures Australia, Melbourne, Victoria
Vivint Smart Home Provo, United States, Utah

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

NeuroTronik

Biotechnology
Health Care
Medical Device
$23M18 Apr 2017 North Carolina, United States

Inspire Medical Systems

Biotechnology
Health Care
Medical Device
Therapeutic Devices
Therapeutics
$38M18 Nov 2016 Minnesota, United States

Inspire Medical Systems

Biotechnology
Health Care
Medical Device
Therapeutic Devices
Therapeutics
$40M15 May 2014 Minnesota, United States

iRhythm Technologies

Health Care
Health Diagnostics
Medical Device
mHealth
Wearables
$16M10 Apr 2013 San Francisco, California, United States

Aptus Endosystems

Health Care
Manufacturing
Medical Device
$25M27 Jun 2012 Sunnyvale, California, United States

Inspire Medical Systems

Biotechnology
Health Care
Medical Device
Therapeutic Devices
Therapeutics
$14M11 May 2012 Minnesota, United States

iRhythm Technologies

Health Care
Health Diagnostics
Medical Device
mHealth
Wearables
$12M01 Jan 2012 San Francisco, California, United States

iRhythm Technologies

Health Care
Health Diagnostics
Medical Device
mHealth
Wearables
$15M04 May 2011 United States, San Francisco

iRhythm Technologies

Health Care
Health Diagnostics
Medical Device
mHealth
Wearables
$10M20 May 2010 San Francisco, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Synergy Life Science Partner?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: